Development of a live oral attaching and effacing Escherichia coli vaccine candidate using Vibrio cholerae CVD 103-HgR as antigen vector

Microbial Pathogenesis

Volumn 48, Issue 1, 2010, Pages 1-8

  Keller, Rogeria ^a   Hilton, Tamara D ^a   Rios, Hernam ^b   Boedeker, Edgar C ^c   Kaper, James B ^a  

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

AEEC; EHEC; EPEC; Intimin; REPEC; Vaccine

Indexed keywords

ADHESIN; BACTERIAL VECTOR; BACTERIUM ANTIBODY; ESCHERICHIA COLI VACCINE; HEMOLYSIN; INTIMIN; OUTER MEMBRANE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BILE; BLOOD SAMPLING; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DIARRHEA; ENTEROPATHOGENIC ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI INFECTION; GENETIC ENGINEERING; INFECTION RESISTANCE; INTESTINE BRUSH BORDER; INTESTINE EPITHELIUM CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENICITY ISLAND; PRIORITY JOURNAL; PROTEIN SECRETION; RABBIT; SALMONELLA TYPHI; SURVIVAL RATE; SYMPTOM; TREATMENT OUTCOME; VIBRIO CHOLERAE; WEIGHT REDUCTION;

ADHESINS, BACTERIAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL SHEDDING; BILE; CHOLERA VACCINES; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; ESCHERICHIA COLI VACCINES; FECES; GENETIC VECTORS; HUMANS; ILEUM; MALE; RABBITS; SALMONELLA TYPHI; SERUM; VACCINES, ATTENUATED;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; ORYCTOLAGUS CUNICULUS; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; VIBRIO CHOLERAE;

EID: 72149134893     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2009.10.005     Document Type: Article

References (37)

1. Nataro J.P., and Kaper J.B. Diarrheagenic Escherichia coli. Clin Microbiol Rev 11 (1998) 142-201
2. Moon H.W., Whipp S., Argenzio R.A., Levine M.M., and Giannella R.A. Attaching and effacing activities of rabbit and human enteropathogenic Escherichia coli in pig and rabbit intestines. Infect Immun 41 (1983) 1340-1351
3. Knutton S., Baldwin T., Williams P.H., and McNeish A.S. Actin accumulation at sites of bacterial adhesion to tissue culture cells: basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli. Infect Immun 57 (1989) 1290-1298
4. An H., Fairbrother J.M., Dubreuil J.D., and Harel J. Cloning and characterization of the eae gene from a dog attaching and effacing Escherichia coli strain 4221. FEMS Microbiol Lett 148 (1997) 239-245
5. Cantey J.R., and Blake R.K. Diarrhea due to Escherichia coli in the rabbit: a novel mechanism. J Infect Dis 135 (1977) 454-462
6. Zhu C., Agin T.S., Elliott S.J., Johnson L.A., Thate T.E., Kaper J.B., et al. Complete nucleotide sequence and analysis of the locus of enterocyte effacement from rabbit diarrheagenic Escherichia coli RDEC-1. Infect Immun 69 (2001) 2107-2115
7. Schauer D.B., and Falkow S. The eae gene of Citrobacter freundii biotype 4280 is necessary for colonization in transmissible murine colonic hyperplasia. Infect Immun 61 (1993) 4654-4661
8. Elliott S.J., Wainwright L.A., McDaniel T.K., Jarvis K.G., Deng Y.K., Lai L.C., et al. The complete sequence of the locus of enterocyte effacement (LEE) from enteropathogenic Escherichia coli E2348/69. Mol Microbiol 28 (1998) 1-4
9. Donnenberg M.S., Kaper J.B., and Finlay B.B. Interactions between enteropathogenic Escherichia coli and host epithelial cells. Trends Microbiol 5 (1997) 109-114
10. Jerse A.E., Yu J., Tall B.D., and Kaper J.B. A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc Natl Acad Sci U S A 87 (1990) 7839-7843
11. Kenny B., Devinney R., Stein M., Reinscheid D.J., Frey E.A., and Finlay B.B. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91 (1997) 511-520
12. Adu-Bobie J., Trabulsi L.R., Carneiro-Sampaio M.M.S., Dougan G., and Frankel G. Identification of immunodominant regions within the C-terminal cell binding domain of intimin alpha and intimin beta from enteropathogenic Escherichia coli. Infect Immun 66 (1998) 5643-5649
13. Oswald E., Schmidt H., Morabito S., Karch H., Marchès O., and Caprioli A. Typing of intimin genes in human and animal enterohemorrhagic and enteropathogenic Escherichia coli: characterization of a new intimin variant. Infect Immun 68 (2000) 64-71
14. Ramachandran V., Brett K., Hornitzky M.A., Dowton M., Bettelheim K.A., Walker M.J., et al. Distribution of intimin subtypes among Escherichia coli isolates from ruminant and human sources. J Clin Microbiol 41 (2003) 5022-5032
15. Zhang W.L., Kohler B., Oswald E., Beutin L., Karch H., Morabito S., et al. Genetic diversity of intimin genes of attaching and effacing Escherichia coli strains. J Clin Microbiol 40 (2002) 4486-4492
16. Tarr C.L., and Whittam T.S. Molecular evolution of the intimin gene in O111 clones of pathogenic Escherichia coli. J Bacteriol 184 (2002) 479-487
17. Ito K., Iida M., Yamazaki M., Moriya K., Moroishi S., Yatsuyanagi J., et al. Intimin types determined by heteroduplex mobility assay of intimin gene (eae)-positive Escherichia coli strains. J Clin Microbiol 45 (2007) 1038-1041
18. Judge N.A., Mason H.S., and O'Brien A.D. Plant cell-based intimin vaccine given orally to mice primed with intimin reduces time of Escherichia coli O157:H7 shedding in feces. Infect Immun 72 (2004) 168-175
19. Dean-Nystrom E.A., Gansheroff L.J., Mills M., Moon H.W., and O'Brien A.D. Vaccination of pregnant dams with intiminO157 protects suckling piglets from Escherichia coli O157:H7 infection. Infect Immun 70 (2002) 2414-2418
20. Ghaem-Maghami M., Simmons C.P., Daniell S., Pizza M., Lewis D., Frankel G., et al. Intimin-specific immune responses prevent bacterial colonization by the attaching-effacing pathogen Citrobacter rodentium. Infect Immun 69 (2001) 5597-5605
21. Galen J.E., Zhao L., Chinchilla M., Wang J.Y., Pasetti M.F., Green J., et al. Adaptation of the endogenous Salmonella enterica serovar Typhi clyA-encoded hemolysin for antigen export enhances the immunogenicity of anthrax protective antigen domain 4 expressed by the attenuated live-vector vaccine strain CVD 908-htrA. Infect Immun 72 (2004) 7096-7106
22. Butterton J.R., Beattie D.T., Gardel C.L., Carroll P.A., Hyman T., Killeen K.P., et al. Heterologous antigen expression in Vibrio cholerae vector strains. Infect Immun 63 (1995) 2689-2696
23. Butterton J.R., Ryan E.T., Acheson D.W., and Calderwood S.B. Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains. Infect Immun 65 (1997) 2127-2135
24. Wai S.N., Lindmark B., Söderblom T., Takade A., Westermark M., Oscarsson J., et al. Vesicle-mediated export and assembly of pore-forming oligomers of the enterobacterial ClyA cytotoxin. Cell 115 (2003) 25-35
25. Cravioto A., Tello A., Villafán H., Ruiz J., del Vedovo S., and Neeser J.R. Inhibition of localized adhesion of enteropathogenic Escherichia coli to HEp-2 cells by immunoglobulin and oligosaccharide fractions of human colostrum and breast milk. J Infect Dis 163 (1991) 1247-1255
26. Camara L.M., Carbonare S.B., Silva M.L., and Carneiro-Sampaio M.M. Inhibition of enteropathogenic Escherichia coli (EPEC) adhesion to HeLa cells by human colostrum: detection of specific sIgA related to EPEC outer-membrane proteins. Int Arch Allergy Immunol 103 (1994) 307-310
27. Frankel G., Candy D.C.A., Fabiani E., Adu-Bobie J., Gil S., Novakova M., et al. Molecular characterization of a carboxy-terminal eukaryotic-cell-binding domain of intimin from enteropathogenic Escherichia coli. Infect Immun 63 (1995) 4323-4328
28. Luo Y., Frey E.A., Pfuetzner R.A., Creagh A.L., Knoechel D.G., Haynes C.A., et al. Crystal structure of enteropathogenic Escherichia coli intimin-receptor complex. Nature 405 (2000) 1073-1077
29. Batchelor M., Prasannan S., Daniell S., Reece S., Connerton I., Bloomberg G., et al. Structural basis for recognition of the translocated intimin receptor (Tir) by intimin from enteropathogenic Escherichia coli. EMBO J 19 (2000) 2452-2464
30. Kaper J.B., and Tacket C. Attenuated Vibrio cholerae strains as live oral cholerae vaccines and vectors. In: Levine M.M., Kaper J.B., Rappuoli R., Liu M., and Goods M. (Eds). New generation vaccines (2004), Marcel Dekker Inc, New York 511-517
31. Ketley J.M., Michalski J., Galen J., Levine M.M., and Kaper J.B. Construction of genetically marked Vibrio cholerae O1 vaccine strains. FEMS Microbiol Lett 111 (1993) 15-21
32. Levine M.M., Kaper J.B., Herrington D., Ketley J., Losonsky G., Tacket C.O., et al. Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR. Lancet 2 (1988) 467-470
33. Acheson D.W., Levine M.M., Kaper J.B., and Keusch G.T. Protective immunity to Shiga-like toxin I following oral immunization with Shiga-like toxin I B-subunit-producing Vibrio cholerae CVD 103-HgR. Infect Immun 64 (1996) 355-357
34. Boullier S., Nougayrède J.P., Marchès O., Tasca C., Boury M., Oswald E., et al. Genetically engineered enteropathogenic Escherichia coli strain elicits a specific immune response and protects against a virulent challenge. Microbes Infec 5 (2003) 857-867
35. Sambrook J., and Russel D.W. Molecular cloning: a laboratory manual (2001), Cold Spring Harbor Laboratory Press, Cold Spring Harbor
36. Zhu C., Feng S., Thate T.E., Kaper J.B., and Boedeker E.C. Towards a vaccine for attaching/effacing Escherichia coli: a LEE encoded regulator (ler) mutant of rabbit enteropathogenic Escherichia coli is attenuated, immunogenic, and protects rabbits from lethal challenge with the wild-type virulent strain. Vaccine 24 (2006) 3845-3855
37. Marchès O., Nougayrède J.P., Boullier S., Mainil J., Charlier G., Raymond I., et al. Role of tir and intimin in the virulence of rabbit enteropathogenic Escherichia coli serotype O103:H2. Infect Immun 68 (2000) 2171-2182